"The
Report PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) -
Global Drug Forecast and Market Analysis to 2024 provides information
on pricing, market analysis, shares, forecast, and company profiles
for key industry participants. - MarketResearchReports.biz"
Attention
deficit hyperactivity disorder (ADHD) is characterized by excessive
levels of inattention, impulsivity, and hyperactivity, either alone
or in combination that have a significant social impact through
disruptions at school, work, home, and in relationships. The majority
of children with the disorder will continue to experience symptoms
into adolescence. 30-50% of children diagnosed with ADHD continue to
have problems into adulthood resulting in 2-5% of adults having ADHD.
Growth
is expected in the global ADHD marketplace, despite the market being
widely genericized. This will be driven largely by the anticipated
launch of assets from the heavily populated ADHD pipeline, as these
products offer clinical advantages that will drive strong uptake.
Furthermore, the number of drug-treated patients will increase over
the forecast period, driven by increased treatment rates throughout
the 7MM, particularly in the adult age group.
View Report At
http://www.marketresearchreports.biz/analysis/885285
Highlights
Key Questions Answered
-
The ADHD market has been dominated by stimulant therapy, with only
three approved non-stimulant drugs approved that cannot compete with
stimulant drugs in terms of efficacy. Due to lack of evidence for
long-term safe use of stimulants, non-stimulants are becoming
increasingly popular in the 7MM. Both stimulant and non-stimulant
therapies are anticipated to reach the market within the forecast
period. How will these change the market overall during the forecast
period? Will stimulants maintain market dominance in 2024?
-
The current late stage ADHD pipeline is heavily populated, drugs
designed to satisfy what GlobalData has identified as unmet needs.
Which of these will have the biggest impact on the market? What
strategies are developers undertaking to penetrate this crowded
market?
-
ADHD is becoming increasingly recognized, particularly n the adult
population, leading to increase number in treated patients across the
7MM. How will these changes impact the growth of the future market?
Key Findings
-
The main driver of growth in the ADHD market will be the increase in
the number of drug-treated patients, driven by an increase in
treatment rates expected to 2024, particularly in the adult age
group.
-
Lack of awareness and recognition of ADHD leads to misdiagnosis; this
has acted as a barrier to appropriate treatment for ADHD.
-
The arrival of new therapies across the 7MM will increase treatment
rates and provide alternative options for many patients, particularly
those who have difficulty or who dislike swallowing pills and those
who choose non-stimulant therapy.
-
One of the key unmet needs in the ADHD market of additional treatment
options will be somewhat satisfied by the emerging pipeline assets
during the forecast. Despite the increasingly competitive nature of
the ADHD market, lucrative opportunities remain for products that
target unmet needs. In addition, providing clinically relevant,
head-to-head comparisons is an important consideration for companies
developing drugs to treat these patients.
Download
Sample copy of this Report at :
www.marketresearchreports.biz/sample/sample/885285
Scope
-
Overview of ADHD, including epidemiology, etiology, pathophysiology,
symptoms, diagnosis, and treatment guidelines.
-
Annualized ADHD market revenue, annual cost of therapy and treatment
usage pattern data from 2014 and forecast for ten years to 2024.
-
Key topics covered include market characterization, unmet needs, R&D
and clinical trials assessment, late stage clinical trial analysis
and implications for the ADHD therapeutics market.
-
Pipeline analysis: focus on 13 late-stage pipeline ADHD drugs
discussing emerging trends as well as an overview of earlier phase
drugs.
-
Analysis of the current and future market competition in the global
ADHD therapeutics market. Insightful review of the key industry
drivers, restraints and challenges. Each trend is independently
researched to provide qualitative analysis of its implications.
Reasons
to buy
The
report will enable you to -
-
Develop and design your in-licensing and out-licensing strategies
through a
review
of pipeline products and technologies, and by identifying the
companies with the most robust pipeline. Additionally a list of
acquisition targets included in the pipeline product company list.
-
Develop business strategies by understanding the trends shaping and
driving the global ADHD therapeutics market.
-
Drive revenues by understanding the key trends, innovative products
and technologies, market segments, and companies likely to impact the
global ADHD therapeutics market in future.
-
Formulate effective sales and marketing strategies by understanding
the competitive landscape and by analysing the performance of various
competitors.
-
Identify emerging players with potentially strong product portfolios
and create effective counter-strategies to gain a competitive
advantage.
-
Track drug sales in the global ADHD therapeutics market from
2014-2024.
-
Organize your sales and marketing efforts by identifying the market
categories and segments that present maximum opportunities for
consolidations, investments and strategic partnerships.
Table
of Contents
1 Table of Contents 11
1.1 List of Tables 17
1.2 List of Figures 24
2 Introduction 26
2.1 Catalyst 26
2.2 Related Reports 27
2.3 Upcoming Related Reports 27
3 Disease Overview 28
3.1 Etiology and Pathophysiology
28
3.1.1 Etiology 28
3.1.2 Pathophysiology 31
3.2 Classification 32
3.2.1 Predominantly Inattentive
Type 33
3.2.2 Predominantly
Hyperactive-Impulsive Type 33
3.2.3 Combined Type 34
3.2.4 Other Specified ADHD Type 34
3.2.5 Unspecified Type 34
3.2.6 Severity 34
3.3 Symptoms 35
3.4 Prognosis 36
4 Epidemiology 38
4.1 Disease Background 38
4.2 Risk Factors and Comorbidities
39
4.3 Global Trends 41
4.3.1 US 41
4.3.2 5EU 41
4.3.3 Japan 43
4.4 Forecast Methodology 43
4.4.1 Sources Used Tables 44
4.4.2 Forecast assumptions and
methods 48
4.4.3 Sources Not Used 61
4.5 Epidemiological Forecast for
ADHD (2014-2024) 62
4.5.1 Diagnosed Prevalent Cases of
ADHD 62
4.5.2 Age-Specific Diagnosed
Prevalent Cases of ADHD 64
4.5.3 Sex-Specific Diagnosed
Prevalent Cases of ADHD 66
4.5.4 Age-Standardized Prevalence
of ADHD 68
4.5.5 Diagnosed Prevalent Cases of
ADHD by Subtype 69
4.6 Discussion 73
4.6.1 Epidemiological Forecast
Insight 73
4.6.2 Limitations of the Analysis
75
4.6.3 Strengths of the Analysis 76
5 Disease Management 77
5.1 Diagnosis and Treatment
Overview 77
5.1.1 Diagnosis 77
5.1.2 Treatment Guidelines and
Leading Prescribed Drugs 79
5.1.3 Clinical Practice 84
5.2 US 85
About
us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
State
Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
No comments:
Post a Comment